This inventor holds 1 USPTO granted patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Brian James Bleakley: Innovator in Cell-Based Screening Assays
Introduction
Brian James Bleakley is an accomplished inventor based in Brier, WA (US). He has made significant contributions to the field of biotechnology, particularly in the design of cell-based screening assays. His innovative approach has the potential to enhance the efficiency and effectiveness of experimental designs in this area.
Latest Patents
Brian holds a patent for "Methods and user interfaces for designing cell-based screening assay experiments." This patent outlines a method that involves receiving inputs through a graphical user interface to define various parameters for conducting cell-based screening assays. The method includes identifying template plate definitions, disease reagents, treatment reagents, and generating a design for the experiment based on these inputs. This invention is crucial for researchers looking to streamline their experimental processes.
Career Highlights
Brian is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in biotechnology and assay design. His work focuses on developing innovative solutions that can lead to breakthroughs in drug discovery and disease treatment. With a strong foundation in scientific research, Brian has positioned himself as a key player in the industry.
Collaborations
Brian collaborates with talented individuals such as Adam Smith Murray and Anthus John Williams. These partnerships enhance the creative and innovative processes within his work environment, fostering a culture of collaboration and shared knowledge.
Conclusion
Brian James Bleakley is a notable inventor whose work in cell-based screening assays is paving the way for advancements in biotechnology. His patent and contributions to Recursion Pharmaceuticals, Inc. reflect his commitment to innovation and excellence in the field.